ATE173633T1 - Therapeutisches agenz aus mycobacterium vaccae und seine verwendung gegen eine hiv-infektion mit aids - Google Patents

Therapeutisches agenz aus mycobacterium vaccae und seine verwendung gegen eine hiv-infektion mit aids

Info

Publication number
ATE173633T1
ATE173633T1 AT93905520T AT93905520T ATE173633T1 AT E173633 T1 ATE173633 T1 AT E173633T1 AT 93905520 T AT93905520 T AT 93905520T AT 93905520 T AT93905520 T AT 93905520T AT E173633 T1 ATE173633 T1 AT E173633T1
Authority
AT
Austria
Prior art keywords
aids
therapeutic agent
hiv infection
against hiv
use against
Prior art date
Application number
AT93905520T
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of ATE173633T1 publication Critical patent/ATE173633T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93905520T 1992-09-14 1993-03-05 Therapeutisches agenz aus mycobacterium vaccae und seine verwendung gegen eine hiv-infektion mit aids ATE173633T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219425A GB9219425D0 (en) 1992-09-14 1992-09-14 Therapeutic agent and its use

Publications (1)

Publication Number Publication Date
ATE173633T1 true ATE173633T1 (de) 1998-12-15

Family

ID=10721884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905520T ATE173633T1 (de) 1992-09-14 1993-03-05 Therapeutisches agenz aus mycobacterium vaccae und seine verwendung gegen eine hiv-infektion mit aids

Country Status (18)

Country Link
EP (1) EP0661998B1 (de)
JP (1) JPH06100457A (de)
KR (1) KR100272743B1 (de)
CN (1) CN1060937C (de)
AP (1) AP510A (de)
AT (1) ATE173633T1 (de)
AU (1) AU683835B2 (de)
BR (1) BR9303762A (de)
CA (1) CA2105646A1 (de)
DE (1) DE69322280T2 (de)
DK (1) DK0661998T3 (de)
ES (1) ES2125331T3 (de)
GB (1) GB9219425D0 (de)
HK (1) HK1011289A1 (de)
RU (1) RU2106878C1 (de)
SG (1) SG72610A1 (de)
WO (1) WO1994006466A1 (de)
ZA (1) ZA935575B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
RU2197989C2 (ru) * 1996-12-18 2003-02-10 Стэнфорд Рук Лимитед ПРИМЕНЕНИЕ Mycobacterium vaccae ДЛЯ РЕГУЛЯЦИИ ПО ТИПУ ОТРИЦАТЕЛЬНОЙ ОБРАТНОЙ СВЯЗИ Th2-АКТИВНОСТИ ИММУННОЙ СИСТЕМЫ
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
CA2472481A1 (en) * 2001-01-17 2002-07-25 Bakulesh Mafatlal Khamar Use of mycobacterium w for the treatment of human immunodeficiency virus (hiv) disease infection
EP1368044B1 (de) * 2001-01-17 2009-03-18 Mafatlal Khamar Bakulesh Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
BR0307262A (pt) * 2002-01-29 2006-12-19 Bakulesh Mafatlal Khamar método de prover profilaxia para tuberculose em indivìduos hiv positivos
WO2003075825A2 (en) * 2002-03-08 2003-09-18 Modi, Rajiv, Indravadan The method of treating tuberculosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use

Also Published As

Publication number Publication date
EP0661998A1 (de) 1995-07-12
KR100272743B1 (ko) 2000-11-15
JPH06100457A (ja) 1994-04-12
EP0661998B1 (de) 1998-11-25
SG72610A1 (en) 2001-07-24
AP9300555A0 (en) 1993-10-31
CN1089478A (zh) 1994-07-20
RU2106878C1 (ru) 1998-03-20
CN1060937C (zh) 2001-01-24
DE69322280T2 (de) 1999-04-22
DE69322280D1 (de) 1999-01-07
GB9219425D0 (en) 1992-10-28
KR950703360A (ko) 1995-09-20
AP510A (en) 1996-07-23
AU3642093A (en) 1994-04-12
ES2125331T3 (es) 1999-03-01
DK0661998T3 (da) 1999-08-09
BR9303762A (pt) 1994-03-22
HK1011289A1 (en) 1999-07-09
AU683835B2 (en) 1997-11-27
ZA935575B (en) 1994-03-01
WO1994006466A1 (en) 1994-03-31
CA2105646A1 (en) 1994-03-15

Similar Documents

Publication Publication Date Title
DE69306402T2 (de) Niedrigschmelzendes tetrafluorethylene-copolymer und seine verwendung
ATE173633T1 (de) Therapeutisches agenz aus mycobacterium vaccae und seine verwendung gegen eine hiv-infektion mit aids
ATA901392A (de) Hepatitis-c-diagnosemittel und -impfstoffe
DE69328528D1 (de) D-Ketohexose-3-Epimerase, und seine Herstellung und Verwendung
DE69214156D1 (de) Bipolare temporäre schrittmacherleitung und kupplung
DD136694A5 (de) Insektizide und akarizide mittel
DE69232988D1 (de) Repamycinderivat und seine medizinische verwendung
DE69228757T2 (de) Biegbare dissektomiesonde und steuerbare kanüle
DE69330509D1 (de) Gleitbauteil und seine herstellung
DE69401007T2 (de) Aus Katheter und Hülse bestehende Einheit
DE69228492D1 (de) 3,4,N-Trisubstituierte-4,5-dihydro-1H-Pyrazol-1-carboxamide und deren Anwendung als Insektizide
DE69310313T2 (de) Feines schalenförmiges teilchen und seine herstellung
DE69311404T2 (de) Bindemittel und seine Verwendungen
DD138932A5 (de) Insektizide und akarizide mittel
DE69021304T2 (de) Vorbeugendes und therapeutisches Mittel gegen Hepatitis.
DE69115649T2 (de) Isotaktisches Polyglycidylnitrat und Herstellung desselben
DD134720A5 (de) Insektizide und akarizide mittel
DE59306085D1 (de) Haar- und körperbehandlungsmittel
DE68906245D1 (de) Therapeutisches mittel gegen aids.
DE69330385T2 (de) Schützende antigene gegen eine (echinococcus granulosus) infektion und impfstoffe die entsprechende antigene enthalten
DE69325597T2 (de) Niedrigschmelzendes tetrafluoroethylencopolymer und seine verwendung
PT68319A (de) Insektizide und akarizide mittel
ITMI922244A0 (it) Nuove pirazolcarbossamidi ad attivita' insetticida ed acaricida
DE4480337T1 (de) Thermistor-Sinterkörper und diesen verwendende Thermistorvorrichtung
DE59305192D1 (de) Kondensate und deren Verwendung als Oxalkylierungshilfsmittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee